$PAND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pandion Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pandion Therapeutics, Inc.. Get notifications about new insider transactions in Pandion Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | PAND | Pandion Therapeuti ... | Viney Joanne L. | See Remarks | Option Exercise | D | 17.75 | 73,789 | 1,309,755 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Viney Joanne L. | See Remarks | Option Exercise | D | 18.00 | 114,876 | 2,067,768 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Viney Joanne L. | See Remarks | Sell | U | 60.00 | 1,200 | 72,000 | 0 | 1.2 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Viney Joanne L. | See Remarks | Sell | U | 60.00 | 503,254 | 30,195,240 | 0 | 503.3 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | D | 17.75 | 73,789 | 1,309,755 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | D | 18.00 | 28,227 | 508,086 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Sell | U | 60.00 | 87,764 | 5,265,840 | 0 | 87.8 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Option Exercise | D | 18.00 | 13,997 | 251,946 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Sell | U | 60.00 | 110,621 | 6,637,260 | 0 | 110.6 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Sell | U | 60.00 | 3,090,801 | 185,448,060 | 0 | 3.1 M to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Sell | U | 60.00 | 336,314 | 20,178,840 | 0 | 336.3 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Sell | U | 60.00 | 84,158 | 5,049,480 | 0 | 84.2 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Freedman Edward D. | Chief Operating Off ... | Option Exercise | D | 17.75 | 36,895 | 654,886 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Freedman Edward D. | Chief Operating Off ... | Option Exercise | D | 18.00 | 55,903 | 1,006,254 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Freedman Edward D. | Chief Operating Off ... | Sell | U | 60.00 | 54,460 | 3,267,600 | 0 | 54.5 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | BELOFF GREGG | See Remarks | Sell | U | 60.00 | 13,196 | 791,760 | 0 | 13.2 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | D | 17.75 | 221,367 | 3,929,264 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | D | 18.00 | 348,741 | 6,277,338 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Sell | U | 60.00 | 702,515 | 42,150,900 | 0 | 702.5 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Sell | U | 60.00 | 14,000 | 840,000 | 0 | 14 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Fuglesang Christopher | Director | Option Exercise | D | 18.00 | 13,997 | 251,946 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Fuglesang Christopher | Director | Sell | U | 60.00 | 23,622 | 1,417,320 | 0 | 23.6 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Fuglesang Christopher | Director | Sell | U | 60.00 | 2,107,513 | 126,450,780 | 0 | 2.1 M to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Option Exercise | D | 18.00 | 13,997 | 251,946 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Sell | U | 60.00 | 2,827,883 | 169,672,980 | 0 | 2.8 M to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Sell | U | 60.00 | 1,000 | 60,000 | 0 | 1,000 to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Sundy John | Chief Medical Offic ... | Option Exercise | D | 17.75 | 73,789 | 1,309,755 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Sundy John | Chief Medical Offic ... | Option Exercise | D | 18.00 | 145,420 | 2,617,560 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Sundy John | Chief Medical Offic ... | Sell | U | 60.00 | 115,826 | 6,949,560 | 0 | 115.8 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Stagliano Nancy | Director | Option Exercise | D | 18.00 | 17,671 | 318,078 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Stagliano Nancy | Director | Sell | U | 60.00 | 73,067 | 4,384,020 | 0 | 73.1 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Stagliano Nancy | Director | Sell | U | 60.00 | 1,000 | 60,000 | 0 | 1,000 to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Dorton Katina | Director | Option Exercise | D | 16.96 | 27,994 | 474,778 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Frail Donald | Director | Option Exercise | D | 18.00 | 18,747 | 337,446 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Frail Donald | Director | Sell | U | 60.00 | 61,113 | 3,666,780 | 0 | 61.1 K to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Option Exercise | D | 18.00 | 13,997 | 251,946 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Sell | U | 60.00 | 5,674,221 | 340,453,260 | 0 | 5.7 M to 0 (-100.00 %) |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Carlo Rizzuto | Director | Option Exercise | D | 18.00 | 13,997 | 251,946 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Larson Eric D | Vice President, Fin ... | Option Exercise | D | 17.75 | 23,000 | 408,250 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Larson Eric D | Vice President, Fin ... | Option Exercise | D | 18.00 | 27,500 | 495,000 | 0 | |
Apr 01 2021 | PAND | Pandion Therapeuti ... | Larson Eric D | Vice President, Fin ... | Sell | U | 60.00 | 22,125 | 1,327,500 | 0 | 22.1 K to 0 (-100.00 %) |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | A | 17.75 | 221,367 | 3,929,264 | 221,367 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Freedman Edward D. | Chief Operating Off ... | Option Exercise | A | 17.75 | 36,895 | 654,886 | 36,895 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | A | 17.75 | 221,367 | 3,929,264 | 221,367 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Viney Joanne L. | See Remarks | Option Exercise | A | 17.75 | 73,789 | 1,309,755 | 73,789 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Freedman Edward D. | Chief Operating Off ... | Option Exercise | A | 17.75 | 36,895 | 654,886 | 36,895 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Viney Joanne L. | See Remarks | Option Exercise | A | 17.75 | 73,789 | 1,309,755 | 73,789 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 17.75 | 73,789 | 1,309,755 | 73,789 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Larson Eric D | Vice President, Fin ... | Option Exercise | A | 17.75 | 23,000 | 408,250 | 23,000 | |
Feb 10 2021 | PAND | Pandion Therapeuti ... | Sundy John | Chief Medical Offic ... | Option Exercise | A | 17.75 | 73,789 | 1,309,755 | 73,789 | |
Nov 23 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 15.12 | 197,716 | 2,989,466 | 2,827,883 | 2.6 M to 2.8 M (+7.52 %) |
Nov 19 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 15.26 | 14,197 | 216,646 | 2,630,167 | 2.6 M to 2.6 M (+0.54 %) |
Nov 19 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 15.43 | 13,027 | 201,007 | 2,615,970 | 2.6 M to 2.6 M (+0.50 %) |
Nov 19 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 14.63 | 2,170 | 31,747 | 2,602,943 | 2.6 M to 2.6 M (+0.08 %) |
Nov 19 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 15.26 | 14,197 | 216,646 | 2,630,167 | 2.6 M to 2.6 M (+0.54 %) |
Nov 19 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 15.43 | 13,027 | 201,007 | 2,615,970 | 2.6 M to 2.6 M (+0.50 %) |
Nov 19 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 14.63 | 2,170 | 31,747 | 2,602,943 | 2.6 M to 2.6 M (+0.08 %) |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Option Exercise | C | 0.00 | 2,414,098 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Option Exercise | C | 0.00 | 13,138,905 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Buy | P | 18.00 | 36,111 | 649,998 | 3,086,084 | 3 M to 3.1 M (+1.18 %) |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Buy | C | 0.00 | 3,049,973 | 0 | 3,049,973 | 0 to 3 M |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Option Exercise | C | 0.00 | 2,414,098 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Option Exercise | C | 0.00 | 13,138,905 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Option Exercise | C | 0.00 | 2,414,098 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Buy | P | 18.00 | 10,000 | 180,000 | 10,000 | 0 to 10 K |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Option Exercise | C | 0.00 | 13,138,905 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Buy | P | 18.00 | 36,111 | 649,998 | 3,086,084 | 3 M to 3.1 M (+1.18 %) |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Buy | P | 18.00 | 36,111 | 649,998 | 3,086,084 | 3 M to 3.1 M (+1.18 %) |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Buy | C | 0.00 | 3,049,973 | 0 | 3,049,973 | 0 to 3 M |
Jul 23 2020 | PAND | Pandion Therapeuti ... | ROCHE HOLDING LTD | 10% Owner | Buy | C | 0.00 | 3,049,973 | 0 | 3,049,973 | 0 to 3 M |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Option Exercise | C | 0.00 | 2,414,098 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Option Exercise | C | 0.00 | 13,138,905 | 0 | 0 | |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Buy | P | 18.00 | 10,000 | 180,000 | 10,000 | 0 to 10 K |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Buy | P | 18.00 | 36,111 | 649,998 | 3,086,084 | 3 M to 3.1 M (+1.18 %) |
Jul 23 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Buy | C | 0.00 | 3,049,973 | 0 | 3,049,973 | 0 to 3 M |
Jul 22 2020 | PAND | Pandion Therapeuti ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,184,596 | 0 | 0 | |
Jul 22 2020 | PAND | Pandion Therapeuti ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 18.00 | 361,111 | 6,499,998 | 1,770,023 | 1.4 M to 1.8 M (+25.63 %) |
Jul 22 2020 | PAND | Pandion Therapeuti ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 1,408,912 | 0 | 1,408,912 | 0 to 1.4 M |
Jul 22 2020 | PAND | Pandion Therapeuti ... | GLAXOSMITHKLINE PLC | Director | Option Exercise | A | 18.00 | 13,997 | 251,946 | 13,997 | |
Jul 22 2020 | PAND | Pandion Therapeuti ... | GLAXOSMITHKLINE PLC | Director | Option Exercise | C | 0.00 | 1,776,980 | 0 | 0 | |
Jul 22 2020 | PAND | Pandion Therapeuti ... | GLAXOSMITHKLINE PLC | Director | Option Exercise | C | 0.00 | 7,846,554 | 0 | 0 | |
Jul 22 2020 | PAND | Pandion Therapeuti ... | GLAXOSMITHKLINE PLC | Director | Buy | P | 18.00 | 361,111 | 6,499,998 | 2,248,304 | 1.9 M to 2.2 M (+19.13 %) |
Jul 22 2020 | PAND | Pandion Therapeuti ... | GLAXOSMITHKLINE PLC | Director | Buy | C | 0.00 | 348,469 | 0 | 1,887,193 | 1.5 M to 1.9 M (+22.65 %) |
Jul 22 2020 | PAND | Pandion Therapeuti ... | GLAXOSMITHKLINE PLC | Director | Buy | C | 0.00 | 1,538,724 | 0 | 1,538,724 | 0 to 1.5 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 49,652 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,387,268 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 508,090 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 14,196,152 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Buy | P | 18.00 | 1,248 | 22,464 | 110,621 | 109.4 K to 110.6 K (+1.14 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Buy | P | 18.00 | 34,863 | 627,534 | 3,090,801 | 3.1 M to 3.1 M (+1.14 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Buy | C | 0.00 | 9,736 | 0 | 109,373 | 99.6 K to 109.4 K (+9.77 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Buy | C | 0.00 | 99,637 | 0 | 99,637 | 0 to 99.6 K |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Buy | C | 0.00 | 272,046 | 0 | 3,055,938 | 2.8 M to 3.1 M (+9.77 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Polaris Partners GP VIII, L.L. ... | 10% Owner | Buy | C | 0.00 | 2,783,892 | 0 | 2,783,892 | 0 to 2.8 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Mutz Mitchell | Director | Option Exercise | A | 18.00 | 13,997 | 251,946 | 13,997 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Boxer Capital, LLC | 10% Owner | Option Exercise | C | 0.00 | 120,460 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Boxer Capital, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,064,136 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Boxer Capital, LLC | 10% Owner | Buy | P | 18.00 | 722,222 | 12,999,996 | 2,107,513 | 1.4 M to 2.1 M (+52.14 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Boxer Capital, LLC | 10% Owner | Buy | C | 0.00 | 23,622 | 0 | 23,622 | 0 to 23.6 K |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Boxer Capital, LLC | 10% Owner | Buy | C | 0.00 | 1,385,291 | 0 | 1,385,291 | 0 to 1.4 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Option Exercise | A | 18.00 | 13,997 | 251,946 | 13,997 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 1,776,980 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 7,846,554 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Buy | P | 18.00 | 361,111 | 6,499,998 | 2,248,304 | 1.9 M to 2.2 M (+19.13 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Buy | C | 0.00 | 348,469 | 0 | 1,887,193 | 1.5 M to 1.9 M (+22.65 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Carroll Jill | Director | Buy | C | 0.00 | 1,538,724 | 0 | 1,538,724 | 0 to 1.5 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | JDRF T1D Fund LLC | 10% Owner | Option Exercise | C | 0.00 | 1,132,170 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | JDRF T1D Fund LLC | 10% Owner | Option Exercise | C | 0.00 | 948,225 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | JDRF T1D Fund LLC | 10% Owner | Buy | C | 0.00 | 222,020 | 0 | 426,333 | 204.3 K to 426.3 K (+108.67 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | JDRF T1D Fund LLC | 10% Owner | Buy | C | 0.00 | 204,313 | 0 | 204,313 | 0 to 204.3 K |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Option Exercise | C | 0.00 | 107,768 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Option Exercise | C | 0.00 | 49,652 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Option Exercise | C | 0.00 | 1,387,268 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Option Exercise | C | 0.00 | 508,090 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Option Exercise | C | 0.00 | 14,196,152 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Option Exercise | A | 18.00 | 13,997 | 251,946 | 13,997 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | P | 18.00 | 14,000 | 252,000 | 84,158 | 70.2 K to 84.2 K (+19.95 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | P | 18.00 | 1,248 | 22,464 | 110,621 | 109.4 K to 110.6 K (+1.14 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | P | 18.00 | 34,863 | 627,534 | 3,090,801 | 3.1 M to 3.1 M (+1.14 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | C | 0.00 | 21,133 | 0 | 70,158 | 49 K to 70.2 K (+43.11 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | C | 0.00 | 9,736 | 0 | 109,373 | 99.6 K to 109.4 K (+9.77 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | C | 0.00 | 99,637 | 0 | 99,637 | 0 to 99.6 K |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | C | 0.00 | 272,046 | 0 | 3,055,938 | 2.8 M to 3.1 M (+9.77 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Crane Alan L | Director | Buy | C | 0.00 | 2,783,892 | 0 | 2,783,892 | 0 to 2.8 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Fuglesang Christopher | Director | Option Exercise | C | 0.00 | 7,184,596 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Fuglesang Christopher | Director | Option Exercise | A | 18.00 | 13,997 | 251,946 | 13,997 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Fuglesang Christopher | Director | Buy | P | 18.00 | 722,222 | 12,999,996 | 2,600,773 | 1.9 M to 2.6 M (+38.45 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Fuglesang Christopher | Director | Buy | C | 0.00 | 1,408,913 | 0 | 1,408,913 | 0 to 1.4 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 333,333 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,245,330 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,745,458 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 14,452,795 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 577,544 | 0 | 577,544 | 0 to 577.5 K |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 3,176,507 | 0 | 3,176,507 | 0 to 3.2 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Option Exercise | C | 0.00 | 9,579,462 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Option Exercise | A | 18.00 | 13,997 | 251,946 | 13,997 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 18.00 | 1,000 | 18,000 | 1,000 | 0 to 1,000 |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | P | 18.00 | 722,222 | 12,999,996 | 2,600,773 | 1.9 M to 2.6 M (+38.45 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Becker Daniel J. | Director | Buy | C | 0.00 | 1,878,551 | 0 | 1,878,551 | 0 to 1.9 M |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | C | 0.00 | 35,922 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 18.00 | 10,486 | 188,748 | 10,486 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 18.00 | 13,935 | 250,830 | 13,935 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 18.00 | 3,806 | 68,508 | 3,806 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Buy | P | 18.00 | 1,450 | 26,100 | 87,764 | 86.3 K to 87.8 K (+1.68 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Buy | C | 0.00 | 7,044 | 0 | 86,314 | 79.3 K to 86.3 K (+8.89 %) |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Carlo Rizzuto | Director | Option Exercise | A | 18.00 | 13,997 | 251,946 | 13,997 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | C | 0.00 | 107,768 | 0 | 0 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | A | 18.00 | 100,493 | 1,808,874 | 100,493 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | A | 18.00 | 221,067 | 3,979,206 | 221,067 | |
Jul 21 2020 | PAND | Pandion Therapeuti ... | Kakkar Rahul | Chief Executive Off ... | Option Exercise | A | 18.00 | 27,181 | 489,258 | 27,181 |